Warfarin Therapy
- 24 September 1970
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 283 (13), 691-694
- https://doi.org/10.1056/nejm197009242831307
Abstract
THE coumarin anticoagulants are widely used in the management of thromboembolic vascular disease. Of the coumarin agents, sodium warfarin is the most frequently employed in the United States. Recent studies have advanced our understanding of the pharmacology of warfarin and allow a reassessment of current practice in the initiation and maintenance of warfarin therapy.Warfarin is a water-soluble derivative of coumaric acid. When given by mouth, it is absorbed completely from the small intestine. It is transported in the blood, loosely bound to albumin. Its distribution in the body and in body fluids, therefore, is essentially the "albumin space." However, . . .Keywords
This publication has 9 references indexed in Scilit:
- Kinetics of pharmacologic effects in man: The anticoagulant action of warfarinClinical Pharmacology & Therapeutics, 1969
- Studies on Coumarin Anticoagulant DrugsCirculation, 1968
- Effect of Heparin on the One-Stage Prothrombin TimeAnnals of Internal Medicine, 1967
- Human sources and absorption of vitamin K in relation to anticoagulation stabilityJAMA, 1965
- Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant DrugsNew England Journal of Medicine, 1964
- A clinical and family study of hereditary proconvertin (factor VII) deficiencyThe American Journal of Medicine, 1964
- STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN*Journal of Clinical Investigation, 1963
- THE ANTITHROMBOTIC PROPERTIES OF COUMARIN DRUGSAnnals of Internal Medicine, 1961
- Evidence for an antithrombotic effect of DicumarolAmerican Journal of Physiology-Legacy Content, 1960